SCHEMBL26040974

SCHEMBL26040974

CCc1cc2c(s1)CCO[C@@]21CCN(CC2CN(C(=O)CS(C)(=O)=O)C2)[C@@H](C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26041035 0.94 — —
SCHEMBL26041029 0.92 — —
SCHEMBL26040880 0.91 — —
SCHEMBL26040979 0.90 — —
SCHEMBL26041032 0.89 SMN1; SMN2 (0.35) —
SCHEMBL26040972 0.88 — —
SCHEMBL26040981 0.88 — —
SCHEMBL26040876 0.88 — —
SCHEMBL26040931 0.88 NPY5R (0.31) —
SCHEMBL26041033 0.86 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154344-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-08-17 — — WO disclosed
Send feedback